{"url_path":"/sec/ttrx/8-k/2026-06-03/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/2023016/0001213900-26-064405-index.html","accession_number":"0001213900-26-064405","cik":"0002023016","ticker":"TTRX","issuer_name":"Turn Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2023016/0001213900-26-064405-index.html","primary_entity_key":"0002023016","primary_entity_name":"Turn Therapeutics Inc."},"word_count":125,"has_tables":true,"body_markdown":"**Item 7.01\nRegulation FD Disclosure.**\n\n \n\nOn June 1, 2026, Turn Therapeutics\nInc. released an updated investor presentation (the “Investor Presentation”). A copy of the Investor Presentation is furnished\nas Exhibit 99.1 to this Current Report on Form 8-K.\n\n \n\nThe information in Item 7.01\nof this Current Report on Form 8-K and the Investor Presentation furnished as Exhibit 99.1 hereto shall not be deemed “filed”\nfor purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to\nthe liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended,\nor the Exchange Act, except as expressly set forth by specific reference in such a filing."}